CJC-1295 + Ipamorelin HUMAN+ vial and carton
HUMAN+CJC + IPA5mg blendCJC + IPA
HUMAN+CJC + IPA5mg blend

Peptides

CJC-1295 + Ipamorelin

★★★★★94 catalog reviews

CJC-1295 + Ipamorelin is presented as a 5 mg blended research formula in the HUMAN+ peptide range. Its page brings the blend format, kit size, code, and product guidance into one place.

$550.00USD · availability shown at checkout
Back to all products →

Your cart is saved locally in this preview.

At a glance

Product details

  • +5 mg blended presentation
  • +Ten-vial research kit
  • +CJC + IPA catalog identifier

Package record

What to verify

Catalog code
CJC + IPA
Format
5mg blend, 10 vial/kit
Collection
Peptides
Presentation
HUMAN+ labeled vial and carton

Care & handling

Before opening

  1. Keep the product sealed and follow the storage directions supplied with the item.
  2. Confirm the name, strength, code, and lot information match the accompanying record.
  3. Review available documentation before use and contact support if anything is unclear.

US / THEM · The documentation difference

Evidence over
empty claims.

A clean label is only the beginning. The HUMAN+ standard is built around product identity, lot-level traceability, inspectable source records, and measured reporting.

H+

HUMAN+ verification standardDesigned to be traceable.

What to compareH+ HUMAN+ standardTypical unverified listing
Product identity✓

CJC-1295 + Ipamorelin, CJC + IPA, and 5mg blend, 10 vial/kit are presented together in one product record.

—

A generic title with missing, incomplete, or inconsistent identifiers.

Lot traceability✓

A lot-matched record is required before verified status should appear on a product.

—

No clear connection between the item being sold and the report being shown.

Certificate access✓

The original independent COA should remain complete, downloadable, and open to inspection.

—

A cropped screenshot, marketing summary, or no source document at all.

Measured reporting✓

Identity and purity values should come directly from the reviewed analytical report.

—

Vague “premium” or “high purity” language without measured evidence.

Source transparency✓

The issuing laboratory or verified manufacturing source should be named on the record.

—

Testing source, report date, methods, or responsible party are not disclosed.

Accountability✓

Product-specific information, a clear support path, and evidence-before-claims review.

—

An anonymous listing with unclear ownership, documentation, or follow-up support.